Thorn Medical PLC appoints Paul Christie as Chief Operating Officer and
Gordon McIvor Wilson as Development Director
London, 17th January, 2017: Thorn Medical PLC (“Thorn” or the “Company”), the international healthcare group, today announces the appointment of Paul Christie as Chief Operating Officer and Gordon McIvor Wilson as Development Director, with immediate effect.
Paul Christie joins from ARACAP International Limited, where he is a Managing Director, focusing on identifying and pioneering new business models and disruptive technologies in frontier and emerging markets for traditional sectors such as insurance and then introducing them to more mature markets. He has extensive management and operational experience in several sectors including healthcare,.
Before that, he was an executive committee member for Emergent Asset Management, where he was a founding member of the World Bank’s committee for responsible investment in agriculture.
Gordon McIvor Wilson joins from Radley Pharma Limited, a life sciences and healthcare business commercialising science and technology, which he founded in 2010 and which is now a subsidiary of Thorn.
Mr Wilson has extensive experience of forming, building and valuing technology businesses and has served on public and private company boards in the engineering, facilities and life sciences fields for over 30 years. He also has considerable experience in corporate finance after earlier qualifying as a Chartered Accountant and working with KPMG after studying chemistry at Edinburgh University.
Jack Kaye, Thorn Medical’s Executive Chairman, said: “We’re delighted to welcome Paul and Gordon to the Board, whose international experience in business operations and development, acquisitions and financing and commercialising scientific and healthcare breakthroughs will be a great help to achieving our challenging global expansion plans.”